Improving Mobility After Revascularization in Peripheral Artery Disease
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- Northwestern University
- Study ID
- NCT06686121
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Intermittent Claudication
- Mobility Limitation
- Peripheral Artery Disease
- Peripheral Vascular Disease
- Revascularization
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Home Based Exercise — BEHAVIORALThis is a six month intervention where participants will walk at home for exercise with guidance from a study coach. They will attend two to four weekly meetings with the coach at the clinical site in the first 4 weeks following randomization, followed by once weekly telephone coaching calls for the remainder of the six-month intervention
- Nitrate Rich Beetroot Juice — DRUGParticipants will drink one shot of nitrate rich beet-root juice twice daily for six months.
- Attention Control — BEHAVIORALParticipants will be asked to participate in weekly meetings with the coach in the attention control group for weeks 1-26. A staff member will present a topic from the National Institute on Aging "age pages" relevant to health, such as cancer screening or blood pressure treatment. Calls will last approximately 5-15 minutes and will focus on educational topics such as diabetes, healthy eating, and Medicare Part D.
- Placebo Beetroot Juice Without Nitrate — DRUGParticipants will drink one shot of placebo beetroot without nitrate juice twice daily for six months.
Study Details
Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ischemia. However, supervised exercise is inaccessible or burdensome for most PAD patients. Investigators hypothesize that home-based exercise combined with lower extremity revascularization will significantly improve walking performance compared to revascularization alone in patients with PAD undergoing revascularization for disabling PAD. Investigators further hypothesize that inorganic nitrate, a major source of nitric oxide (NO) abundant in beetroot juice, will improve walking performance after lower extremity revascularization, compared to placebo. In preclinical models, NO inhibits inflammation, neointimal hyperplasia, thrombosis, and vascular smooth muscle cell migration at sites of revascularization. NO increases angiogenesis and perfusion, repairs skeletal muscle damaged by ischemia, and stimulates mitochondrial activity. In a randomized clinical trial with a 2 x 2 factorial design, the trial will test the following two primary hypotheses in 386 patients randomized within three months of a successful lower extremity revascularization for disabling PAD: First, that home-based exercise combined with lower extremity revascularization will improve six-minute walk distance more than revascularization alone at 6-month follow-up (Primary Aim #1). Second, that nitrate-rich beetroot juice combined with lower extremity revascularization will improve six-minute walk, compared to placebo combined with revascularization at 6-month follow-up (Primary Aim #2).
Key Dates
- Start date
- Aug 4, 2025
- Status verified
- Aug 2025
- Primary completion
- Feb 1, 2032
- Completion
- Aug 1, 2032
Study Design
- Enrollment
- 386 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Home based exercise + nitrate rich beetroot juiceThis group will be participating in home based exercise and drinking nitrate rich beetroot juice for six months.
- Placebo Comparator: Home-based exercise + placeboThis group will be participating in home based exercise and drinking placebo beetroot juice with nitrate removed for six months.
- Experimental: Attention control + nitrate-rich beetroot juiceThis group will be participating in attention control and drinking nitrate rich beetroot juice for six months.
- Placebo Comparator: Attention control + placeboThis group will be participating in attention control and drinking placebo beetroot juice with nitrate removed for six months.
Primary Outcome Measure
Six-Minute Walk Distance 6-month change [ Time Frame: Baseline to 6-month follow-up ]
Central Contacts
- Mary M McDermott, MD312-503-6438
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | Wei Zhou, MD |
| Rancho Research Institute | Downey | California | 90242 | Tze-Woei Tan, MD |
| Emory University School of Medicine | Atlanta | Georgia | 30307 | Olamide Alabi, MD |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | Mary M McDermott, MD (PRINCIPAL_INVESTIGATOR) |
| University of Chicago | Chicago | Illinois | 60637 | Tamar Polonsky, MD 773-702-6153 |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | Philip P Goodney, MD |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | Ulka Sachdev, MD |
Find similar trials in Tucson, AZ
Related Studies
- Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility LossRecruiting · Northwestern University · Chicago, Illinois
- The COCOA-PAD II TrialPHASE3 · Recruiting · Northwestern University · Chicago, Illinois
- Exercise Therapy for PAD Using Mobile HealthRecruiting · VA Office of Research and Development · Decatur, Georgia
- MetfOrmin BenefIts Lower Extremities With Intermittent ClaudicationPHASE3 · Recruiting · VA Office of Research and Development · Pittsburgh, Pennsylvania